Related content

Dendritic cell–tumor cell hybrid vaccination for metastatic cancer

By Barbuto Jose   Ensina Luis   Neves Andreia   Bergami-Santos Patrícia   Leite Katia   Marques Ricardo   Costa Frederico   Martins Siderleny   Camara-Lopes Luiz   Buzaid Antonio  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 12, 2004-12 ,pp. : 1111-1118

Springer Publishing Company

Access to resources Recommend Favorite

Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell–based cancer vaccination

By Galea-Lauri Joanna   Wells James   Darling David   Harrison Phillip   Farzaneh Farzin  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 11, 2004-11 ,pp. : 963-977

Springer Publishing Company

Access to resources Recommend Favorite

Mild hyperthermia enhances human monocyte-derived dendritic cell functions and offers potential for applications in vaccination strategies

By Knippertz Ilka   Stein Marcello F.   Dörrie Jan   Schaft Niels   Müller Ina   Deinzer Andrea   Steinkasserer Alexander   Nettelbeck Dirk M.  

International Journal of Hyperthermia, Vol. 27, Iss. 6, 2011-09 ,pp. : 591-603

Informa Healthcare

Access to resources Recommend Favorite

Dendritic cell-based vaccination in metastatic melanoma patients: Phase II clinical trial

By                            

Oncology Reports, Vol. 28, Iss. 4, 2012-01 ,pp. : 1131-1138

Spandidos Publications

Access to resources Recommend Favorite

Dendritic Cell-Based Vaccines in Cancer: Clinical Experience to Date

By Morse M.A.   Mosca P.J.   Clay T.M.   Lyerly H.K.  

American Journal of Cancer, Vol. 1, Iss. 5, 2002-01 ,pp. : 313-322

Adis International

Access to resources Recommend Favorite